https://www.selleckchem.com/pr....oducts/SB-431542.htm
03). In the AVI model, EPA reduced vascular expression of VCAM1 by 43% (p=0.02) and CCL2 by 41% (p=0.03). Significant inverse correlations were observed between EPA levels and vascular expression of VCAM1 (r=-0.56, p=0.001) and CCL2 (r=-0.56, p=0.001). In ApoE mice, EPA reduced aortic expression of Il1b by 44% (p=0.04) and Tnf by 49% (p=0.04), with similar inverse correlations between EPA levels and both Il1b (r=-0.63, p=0.009) and Tnf (r=-0.50, p=0.04). Supplementation with EPA, more so than DHA, ameliorates acute and chronic vascula